Abstract Recent critiques of the Bill & Melinda Gates Foundation (BMGF) acknowledge, to varying degrees, the malign effects of ‘philanthrocapitalism’ on the people’s health (Aschoff, 2016; McGoey, 2015). Yet these effects are typically portrayed as the unintentional consequences of misguided benevolence. The multi-billionaires mean well, it is suggested, but are somehow too naïve to recognise the inherent limitations of market-based solutions to health crises.
Recent critiques of the Bill & Melinda Gates Foundation (BMGF) acknowledge, to varying degrees, the malign effects of ‘philanthrocapitalism’ on the people’s health (Aschoff, 2016; McGoey, 2015). Yet these effects are typically portrayed as the unintentional consequences of misguided benevolence. The multi-billionaires mean well, it is suggested, but are somehow too naïve to recognise the inherent limitations of market-based solutions to health crises.













